Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Products>This Product

Enable low abundant TH17 Cytokines; Powered by Singulex; High-Definition Erenna® Technology

Product Image
Product Description

Leveraging TH17 pathway biomarkers in chronic inflammatory diseases is highly challenging due to their low abundance. Recent research shows that detection and monitoring of TH17 cytokine concentrations can provide insights into disease progression and thus, cytokines have become attractive biomarkers and candidates for targeted therapies. These biomarkers are key members of the IL-17 signaling pathway, serving to induce and mediate pro-inflammatory responses in numerous immune mediated diseases, such as Rheumatoid Arthritis and asthma, among others.

Powered by Singulex; high-definition Erenna® technology’s powerful suite of TH17 pathway immunoassay kits, with LLoQ down to the sub picogram levels, offers researchers unique and novel insights, enabling quicker and more confident decision making. To Learn More:  Download TH17 Pathway Solutions!

Unless otherwise noted, Singulex products are for research use only and not intended for diagnostics use.

Watch High-Definition Erenna® Technology Video >>



Download TH17 Pathway Solutions!

Product Enable low abundant TH17 Cytokines; Powered by Singulex; High-Definition Erenna® Technology
Company Singulex
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

1701 Harbor Bay Parkway, Alameda, California, 94502, USA

Tel: +1.888.995.6955
Fax: +1.510.995.9090

Scientific News
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Influential Cancer Researcher Receives Agilent Thought Leader Award
Biologist Scott Lowe receives award in recognition for his contributions to cancer biology.
Gene-Editing Cures Genetic Blood Disorder in Mice
New technology may offer minimally invasive treatment for genetic disorders of the blood.
Immunotherapy Technique Holds Promise for Curing Food Allergies
Scientists develop immunotherapy technique that almost eliminating allergic response and anaphylactic response in food-allergic mice.
Antibodies from Ebola Survivors Neutralize Virus, Protect Lab Mice
Scientists discover antiboides generated from the blood of Ebola survivors can strongly combat the virus in the lab.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Observing Direct Inheritance of Gene-Silencing RNA
Research has allowed for the observation of double-stranded RNA molecule being passed from parent to offspring in roundworms.
Editing Gene Mutations in Anemia
Researchers successfully use a new gene editing strategy to correct mutations that cause a form of anemia.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
Nanoparticles Offer Promising Platform for Flavivirus Treatment
New nanoparticle effectively vaccinated mice against one dengue strain and could be created to target all four.


SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos